Clinical Trials Browser

Phase 3 × Methylphenidate × 90 days × Clear all

NCT06905587 2026-04-23

EMBRAIN

Phase 3 Recruiting

Brain Neoplasms, Neoplasms

NCT03525873 2026-04-15

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Phase 3 Active not recruiting

Neoplasm Metastasis, Recurrence